Why is lamotrigine being recalled?

Lamotrigine is being recalled by the manufacturer due to potential contamination with an impurity known as N-nitroso-diethylamine (NDEA). NDEA is a known carcinogen and can be hazardous to human health if ingested. The recall affects all batches of lamotrigine manufactured before December 31, 2021.

There are various forms of drugs available, such as tablets or liquids, and each may have a separate patient information leaflet (PIL) for different doses. It is important to refer to the PIL for the specific form and dose of the drug that you have been prescribed.

You can search for further information and PILs on websites such as: